Clinical Prediction of Blood Parameters Associated with Breast, Colon, Thyroid, Ovarian, and Prostate Cancer
Diagnostic Studies
Abstract
Cancer is a cellular change caused by uncontrolled cell growth and division. This disease develops from the growth of abnormal cells that have the potential to invade or spread to other parts of the body. The aim of this study was to investigate the relationship between blood parameters (e.g., Mean corpuscular volume (MCV), Mean corpuscular hemoglobin (MCH), Mean Corpuscular Hemoglobin Concentration (MCHC), Haemoglobin (HGB), White Blood Cell (WBC), and Red Blood Cell (RBC)) and different types of cancer. Breast cancer, thyroid gland cancer, ovarian cancer, testicular cancer, brain tumors as well as other types of cancer are based on the cell of the tissue found on or in the body. Any of these types of cancer are associated with a variety of health issues that put the patient's life in danger. Performing the complete blood count (CBC) test prior to or after a cancer diagnosis is necessary as abnormalities in the body can cause blood component rates to either increase or decrease, depending on the type of cancer, the patient's physiological mechanism, and the structural component. Since the CBC test belongs to hematology, drawing a blood sample and putting it into the anticoagulant tube for testing were preferred. In this study, the blood components of almost all patients were normal except for a few of them which may be due to other medical and biological factors. There is a significant relationship between blood parameters and cancer types.
Downloads
References
World Health Organization. Cancer Fact Sheets. World Health Organization, Geneva, 2020. Available from: https://gco.iarc.fr/today/fact-sheets-cancers [Last accessed on 2023 Jan 29].
G. Salcedo-Villanueva, A. A. Medina-Andrade, D. MorenoParamo, M. F. Golzarri, E. Moreno-Paramo, G. Y. Ortiz-Ramirez, U. Martinez-Aguilar, U. De Dios-Cuadras, M. Jimenez-Rodriguez, I. Espinosa-Soto, X. Mira-Lorenzo, J. Guzman-Cerda, A. OrozcoMoguel, C. Becerra-Revollo, L. P. Orozco-Gomez and E. Fulda. Primary cancer sites and clinical features of choroidal metastasis in Mexican patients. Clinical Ophthalmology, vol. 15, pp. 201- 209, 2021.
G. N. Sharma, R. Dave, J. Sanadya, P. Sharma and K. K. Sharma. Various types and management of breast cancer: An overview. Journal of Advanced Pharmaceutical Technology and Research, vol. 1, no. 2, pp. 109-126, 2010.
M. Xing. Molecular pathogenesis and mechanisms of thyroid cancer. Nature Reviews Cancer, vol. 13, pp. 184-199, 2013.
D. F. Schneider and H. Chen. New developments in the diagnosis and treatment of thyroid cancer. CA: A Cancer Journal for Clinicians, vol. 63, no. 6, pp. 373-394, 2013.
G. C. Jayson, E. C Kohn, H. C. Kitchener and J. A. Ledermann. Ovarian cancer. Lancet, vol. 384, no. 9951, pp. 1376-1388, 2014.
E. Lengyel. Ovarian cancer development and metastasis. The American Journal of Pathology, vol. 177, no. 3, pp. 1053-1064, 2010.
T. Hu, Z. Li, C. Y. Gao and C. H. Cho. Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World Journal of Gastroenterology, vol. 22, no. 30. pp. 6876-6889, 2016.
P. Rawla. Epidemiology of prostate cancer. World Journal of Oncology, vol. 10, no. 2. pp. 63-89, 2019.
A. Rehman, M. A. Khan, T. Saba, Z. Mehmood, U. Tariq and N. Ayesha. Microscopic brain tumor detection and classification using 3D CNN and feature selection architecture. Microscopy Research and Technique, vol. 84, no. 1, pp. 133-149, 2020.
T. Saba, A. S. Mohamed, M. El-Affendi, J. Amin and M. Sharif. Brain tumor detection using fusion of hand crafted and deep learning features. Cognitive Systems Research, vol. 59, pp. 221- 230, 2020.
G. de Vries, X. Rosas-Plaza, M. A. T. M. van Vugt, J. A. Gietema and S. de Jong. Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities. Cancer Treatment Reviews, vol. 88, p. 102054, 2020.
Y. Iwamoto. Diagnosis and treatment of Ewing’s sarcoma. Japanese Journal of Clinical Oncology, vol. 37, no. 2. pp. 79-89, 2007.
J. J. Noh, M. C. Lim, M. H. Kim, Y. H. Kim, E. S. Song, S. J. Seong, D. H. Suh, J. M. Lee, C. Lee and C. H. Choi. The prognostic model of pre-treatment complete blood count (CBC) for recurrence in early cervical cancer. Journal of Clinical Medicine, vol. 9, no. 9, p. 2960, 2020.
N. H. Mahmood, P. C. Lim, S. M. Mazalan and M. A. A. Razak. Blood cells extraction using color based segmentation technique. International Journal of Life Sciences Biotechnology and Pharma Research, vol. 2, no. 2, pp. 2250-3137, 2013.
D. K. Kur, D. Thøgersen, L. Kjeldsen and L. Friis-Hansen. The HemoScreen hematology point- of-care device is suitable for rapid evaluation of acute leukemia patients. International Journal of Laboratory Hematology, vol. 43, no. 1, pp. 52-60, 2021.
M. G. Sadovsky, A. A. Feller, E. A. Martynova, D. V. Chernyaev, E. V. Semenov, E. V. Slepov and R. A Zukov. CBC effectively stratifies the patients with different types of malignant tumors. Journal of Physics: Conference Series, vol. 1679, p. 042019, 2020.
S. Yousefian, A. Moafi and M. Khalilian. The relation between end of induction minimal residual disease and different risk factors in patients with acute lymphoblastic leukemia. Iranian Journal of Pediatric Hematology and Oncology, vol. 9, no. 4, pp. 211-218, 2019.
N. Michels, C. van Aart, J. Morisse, A. Mullee and I. Huybrechts. Chronic inflammation towards cancer incidence: A systematic review and meta-analysis of epidemiological studies. Critical Reviews in Oncology Hematology, vol. 157, p. 103177, 2021.
A. M. Hussein, Z. B. Taha, A. G. Malek, K. A. Rasul, D. Q. Hazim, R. J. Ahmed and U. B. Mohamed. D- dimer and serum ferritin as an independent risk factor for severity in COVID-19 patients. Materials Today: Proceedings, 2021.
T. S. Salih and S. N. R. Darogha. Incidence of B-cell leukemia among Kurdish people in Erbil City. Cihan University-Erbil Scientific Journal, vol. 2, p. 2, 2017.
Copyright (c) 2023 Ali J. Muhialdin, Zaenah Z. Alamri, Ali M. Hussein, Rahman K. Faraj, Zhala B. Taha, Mohammed M. Hussein, Zeena M. Ameen, Naz R. Majeed, Maryam A. Ameed Akramc, Mohammed I. Jameel

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-ND 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).